Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials


Can a one-off administration of psilocybin reduce alcohol intake in patients with alcohol use disorder? A randomized, double-blinded, placebo-controlled clinical trial.


To see complete record on www.clinicaltrialsregister.eu, please visit this link

Id: 2020-000829-55

Organisation Name: Psychiatric Centre Copenhagen

Start Date: 2020-12-16

Completion Date: Ongoing

Brief Summary: The aim of this research project is to evaluate the effect of a single administration of the 5-HT2A receptor agonist Psilocybin on heavy drinking days from baseline to follow-up after 12 weeks in patients with alcohol use disorder, in a randomized, double-blinded, placebo-controlled clinical trial.

Country: Denmark



Total execution time in seconds: 0.17197895050049